• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC13
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Dysphagia/ Odynophagia (1815); No Code Available (3191)
Event Date 09/23/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).If further details are received at a later date a supplemental medwatch will be sent.
 
Event Description
It was reported that on (b)(6) 2020, the linx device was explanted due to dysphagia.The device was implanted on (b)(6) 2020, and after six months the device was removed.The patient went through two rounds of balloon dilation.No issues during the removal of the device.
 
Manufacturer Narrative
(b)(4).Date sent: 11/4/2020.Lot 22983 was reviewed.No ncs, defects, or reworks related to the product complaint were found.Additional information was requested, and the following was obtained: prior to linx placement, did the patient have an egd, ph, and manometry studies done? per the surgeon yes.At the time the surgeon did not have access to the data.When using the linx sizing device what technique was used to determine the size? the placement technique was standard protocol.The device was placed at a plus 2 of pop off.Did the patient have an autoimmune disease? unknown.Is the patient currently taking steroids/immunization drugs? unknown.Did the patient have any pre-existing dysphagia or other conditions (other than gerd)? unknown.How severe was the dysphagia/odynophagia before intervention? unknown were there any intra-operative complications during implant? unknown was there any hiatal or crural repair done at the same time as the implant? yes were there any other contributing factors that led to the removal of the device other than the reported dysphagia? unknown what was the reason for removal of the linx device? complaints of dysphagia was the device found in the correct position/geometry at the time of removal? yes.Additional information from surgeon: implant date was (b)(6) 2020.We saw patient initially (b)(6) 2016 and she had egd showing medium-sized hiatal hernia, 24-hour ph study was negative for reflux at that time.Manometry (b)(6) 2016 showed normal sphincter pressures with appropriate relaxation.Ten swallows were intact.There was 100% bolus clearance.She had normal motility.She had a repeat egd in (b)(6) 2018 and bravo first day was normal as she slept all day and did not eat.The second day was highly positive with total time of ph less than 4 of 12.4%, demeester score 40.9.We did repeat manometry.I think issue with her was likely size 13 device was too large at time of placement, with probable capsule around but not between magnets, preventing opening and causing dysphagia.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 13B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key10662260
MDR Text Key215265828
Report Number3008766073-2020-00158
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005332
UDI-Public00855106005332
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 09/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/20/2022
Device Model NumberLXMC13
Device Catalogue NumberLXMC13
Device Lot Number22983
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/23/2020
Initial Date FDA Received10/12/2020
Supplement Dates Manufacturer Received10/16/2020
Supplement Dates FDA Received11/04/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-